Allogeneic Stem Cell Transplant Myeloma Trials

Allogeneic Transplant is a type of stem cell transplant that utilizes a donor (not from own) pre-collected stem cell to rescue the bone marrow from the toxic effect of a very high dose chemotherapy.

SparkCures ID	22
Generic Name	Allogeneic Stem Cell Transplant
Treatment Classifications	Allogeneic Stem Cell Transplant

All Clinical Trials

View all active clinical trials around the US.

Verified

Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders

View Trial

Verified

Study of a Geriatric Assessment to Plan a Treatment Approach for Older People With Various Blood Disorders

View Trial

Verified

A Phase II Study of Ruxolitinib Pre-, During, and Post-Hematopoietic Stem Cell Transplantation for Patients with Primary or Secondary Myelofibrosis

View Trial

Verified

A Phase 2 Study of Donor-Derived Multi-Tumor-Associated Antigen-Specific T Cells (MT-401) Administered to Patients with Acute Myeloid Leukemia (AML) followin...

View Trial

Verified

IIT: Rational Use of Broad-spectrum Antibiotics as Empiric Antibiotic Therapy in Febrile Neutropenia in Recipients of Allogeneic Hematopoietic Cell Transplan...

View Trial

Verified

Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation

View Trial

Verified

Allogeneic Hematopoietic Stem Cell Transplantation of αβ+ T Lymphocyte Depleted Grafts Conditioned with a Reduced Intensity Regimen in Patients with Hematolo...

View Trial

Verified

A Pilot Study of Condensed Busulfan, Melphalan, and Fludarabine Conditioning prior to ex vivo CD34+ Selected Allogeneic Hematopoietic Cell Transplantation

View Trial

Verified

Inotuzumab Ozogamicin Post-Transplant for Acute Lymphoblastic Leukemia and Non-Hodgkin Lymphoma

View Trial

Verified

A Phase I/II Study Evaluating the Safety and the Efficacy of SMART101 Human T Lymphoid Progenitor (HTLP) Injection to Accelerate Immune Reconstitution after ...

View Trial

Verified

A Phase 1/2 Study to Evaluate the Safety and Tolerability of Adoptively Transferred T Lymphocytes Targeting WT1, PRAME and Cyclin A1 in Patients with Acute M...

View Trial

Verified

A First-In-Human, Open-Label, Multicenter Study of VOR33 in Patients with Acute Myeloid Leukemia who are at High-Risk for Leukemia Relapse following Hematopo...

View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine Phosphate, and Total-Body Irradiation in Tre...

View Trial

Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transpl...

View Trial

Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in Treating Patients With High-Risk Hemato...

View Trial

Targeting the Inherited Paternal Antigen (IPA) and Matching for the Non-Inherited Maternal Antigen (NIMA) f...

View Trial

Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases

View Trial

Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients...

View Trial

Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning (RIC) for the Treat...

View Trial

UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep

View Trial

Personalized Natural Killer (NK) Cell Therapy in Cord Blood Transplantation (CBT)

View Trial

Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating...

View Trial

Reduce Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed Multiple Myeloma

View Trial

Myeloablative Allogeneic Hematopoietic Stem Cell Transplant With Related or Unrelated Donor for Hematologic...

View Trial

²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor...

View Trial

Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transpl...

View Trial

Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Ma...

View Trial

Untreated / Newly Diagnosed Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have been newly diagnosed or have not yet received treatment.

Verified

Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders

View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transpl...

View Trial

Targeting the Inherited Paternal Antigen (IPA) and Matching for the Non-Inherited Maternal Antigen (NIMA) f...

View Trial

²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor...

View Trial

Early Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.

Verified

Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders

View Trial

Verified

Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation

View Trial

Verified

Allogeneic Hematopoietic Stem Cell Transplantation of αβ+ T Lymphocyte Depleted Grafts Conditioned with a Reduced Intensity Regimen in Patients with Hematolo...

View Trial

Verified

A Pilot Study of Condensed Busulfan, Melphalan, and Fludarabine Conditioning prior to ex vivo CD34+ Selected Allogeneic Hematopoietic Cell Transplantation

View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine Phosphate, and Total-Body Irradiation in Tre...

View Trial

Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transpl...

View Trial

Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in Treating Patients With High-Risk Hemato...

View Trial

Targeting the Inherited Paternal Antigen (IPA) and Matching for the Non-Inherited Maternal Antigen (NIMA) f...

View Trial

Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases

View Trial

Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients...

View Trial

UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep

View Trial

Personalized Natural Killer (NK) Cell Therapy in Cord Blood Transplantation (CBT)

View Trial

Reduce Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed Multiple Myeloma

View Trial

Myeloablative Allogeneic Hematopoietic Stem Cell Transplant With Related or Unrelated Donor for Hematologic...

View Trial

²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor...

View Trial

Late Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.

Verified

Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders

View Trial

Verified

Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation

View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine Phosphate, and Total-Body Irradiation in Tre...

View Trial

Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transpl...

View Trial

Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in Treating Patients With High-Risk Hemato...

View Trial

Targeting the Inherited Paternal Antigen (IPA) and Matching for the Non-Inherited Maternal Antigen (NIMA) f...

View Trial

Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases

View Trial

Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients...

View Trial

Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning (RIC) for the Treat...

View Trial

UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep

View Trial

Personalized Natural Killer (NK) Cell Therapy in Cord Blood Transplantation (CBT)

View Trial

Reduce Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed Multiple Myeloma

View Trial

Myeloablative Allogeneic Hematopoietic Stem Cell Transplant With Related or Unrelated Donor for Hematologic...

View Trial

²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor...

View Trial

Smoldering Myeloma

No active clinical trials

Monoclonal Gammopathy of Undetermined Significance (MGUS)

No active clinical trials

Allogeneic Transplant and Precursor Myeloma Cells with William Matsui, MD, Johns Hopkins

February 16, 2018

Allogeneic (or donor) stem cell transplant has become much safer over the last 20 years. For those who have high risk myeloma features, it should be considered as a potential option. Dr. William Matsui, MD of Johns Hopkins University (and soon to be leading a myeloma practice in Austin, TX) shares his experience with allo transplant for all patients, regardless of their age.

Allogeneic Stem Cell Transplant

Overview

Clinical Trials

Resources